Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04517734 · ClinicalTrials.gov registry record
Erythroferrone and Its Impact on Maternal and Neonatal Iron Homeostasis
A clinical trial, sponsored by Cornell University.
- Completed
- Registry status
- 338
- Enrollment target
NCT04517734 is a clinical trial that has completed, run by Cornell University. The registered enrollment target is 338 participants.
The verdict
NCT04517734 has completed, sponsored by Cornell University.
- COMPLETED
- Registry status
- 338 participants
- Enrollment target
Study Summary
Erythroferrone (ERFE) is a recently identified iron-regulatory hormone that couples iron homeostasis to erythropoiesis but at this time there are no human data on this hormone in pregnant women and their neonates. The investigators hypothesize that ERFE is a sensitive biomarker of iron deficiency and anemia in pregnancy and neonates, and that it mediates the feedback mechanism to correct iron deficiency and anemia. To address this research gap, the investigators will measure ERFE in maternal serum, umbilical cord serum and placental tissue using an existing biospecimen archive.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 338 participants |
| Start Date | 2006-04 |
| Est. Completion | 2017-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04517734
The ClinicalTrials.gov registry entry for NCT04517734 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 338 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cornell University, which has 66 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04517734 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04517734 about?
NCT04517734 is a clinical study titled "Erythroferrone and Its Impact on Maternal and Neonatal Iron Homeostasis". Erythroferrone (ERFE) is a recently identified iron-regulatory hormone that couples iron homeostasis to erythropoiesis but at this time there are no human data on this hormone in pregnant women and their neonates. The investigators hypothesize that ERFE is a sensitive biomarker of iron deficiency an...
What is the current status of trial NCT04517734?
This trial is currently completed. The enrollment target is 338 participants. The study started on 2006-04. Estimated completion is 2017-12.
Who is sponsoring clinical trial NCT04517734?
This trial is sponsored by Cornell University, which has 66 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.